Although BRCA2 c.771_775del (999del5) is the major founder mutation in Icelander breast cancer (Thorlacius et al, 1997), it was not present in the 27 DDR deleterious variants identified in the Icelander population of 12,584 individuals included in our study. This evidence concerns the gene BRCA2 and breast carcinoma.